Expression of the B7-Related Molecule B7-H1 by Glioma Cells: A Potential Mechanism of Immune Paralysis

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7462-7467

  Wintterle, Sabine ^a   Schreiner, Bettina ^a   Mitsdoerffer, Meike ^a   Schneider, Dagmar ^a   Chen, Lieping ^b   Meyermann, Richard ^a   Weller, Michael ^a   Wiendl, Heinz ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; MONOCLONAL ANTIBODY 5H1; NEUTRALIZING ANTIBODY; PROTEIN B7; PROTEIN B7 H1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLOIMMUNITY; ANTIGEN RECOGNITION; ARTICLE; BRAIN TISSUE; CANCER IMMUNOLOGY; CELL DESTRUCTION; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 0242442492     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Boon, T., Cerottini, J. C., Van den Eynde, B., van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12: 337-365, 1994.
2. Tureci, O., Sahin, U., and Pfreundschuh, M., Serological analysis of human tumor antigens: molecular definition and implications. Mol. Med. Today, 3: 342-349, 1997.
3. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., and Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol., 3: 991-998, 2002.
4. Whiteside, T. L., Immune responses to malignancies. J. Allergy Clin. Immunol., 111: S677-S686, 2003.
5. Coyle, A. J., and Gutierrez-Ramos, J. C. The expanding B7 superfamily: increasing complexity in costimulatory signals, regulating T cell function. Nat. Immunol., 2: 203-209, 2001.
6. Carreno, B. M., and Collins, M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol., 20: 29-53, 2002.
7. Lenschow, D. J., Walunas, T. L., and Bluestone, J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol., 14: 233-258, 1996.
8. Chambers, C. A. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol., 22: 217-223, 2001.
9. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T-lymphocyle molecules CD28 and CTLA-4. Cell 71: 1093-1102, 1992.
10. Walker, P. R., Calzascia, T., and Dietrich, P. Y. All in the head: obstacles for immune rejection of brain tumours. Immunology., 107: 28-38, 2002.
11. Liang, L., and Sha, W. C. The right place at the right time: novel B7 family members regulate effector T-cell responses. Curr. Opin. Immunol., 14: 384-390, 2002.
12. Sharpe, A. H., and Freeman, G. J. The B7-CD28 superfamily. Nat. Rev. Immunol., 2: 116-126, 2002.
13. Dong, H., Zhu, G., Tamada, K., and Chen, L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion [see comments]. Nat. Med., 5: 1365-1369, 1999.
14. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R. Carreno, B. M., Collins, M., Wood, C. R., and Honjo, T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med., 192: 1027-1034, 2000.
15. Carter, L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., and Carreno, B. M. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol., 32: 634-643, 2002.
16. Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., and Honjo, T. PD-1 immunoreceptor inhibits B-cell receptor-rnediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA, 98: 13866-13871, 2001.
17. Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B. Roche, P. C. Lu, J., Zhu, G., Tamada, K., Lennon, V. A., Celis, E., and Chen, L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med., 8: 793-800, 2002.
18. Wiendl, H., Mitsdoerffer, M., Wischhusen, J., Hofmeister, V., Bornemann, A., Meyermann, R., Weiss, E., Melms, A., and Weller M. A. functional role of HLA-G-expression in human gliomas: art alternative strategy of immune escape. J. Immunol., 268: 4772-4780, 2002.
19. Wiendi, H., Mitsdoerffer, M., Schneider, D., Melms, A., Lochmuller, H., Hohifeld, R., and Weller, M. Muscle fibers and cultured muscle cells express the B71/2 related costimulatory molecule ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain., 126: 1026-1035, 2003.
20. Wischhusen, J., Jung, G., Radovanovic, I., Beier, C., Steinbach, J. P., Rimner, A., Huang, H., Schulz, J. B., Ohgaki, H., Aguzzi, A., Rammensee, H. G., and Weller, M. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer. Res., 62: 2592-2599, 2002.
21. Marincola, F. M., Jaffee, E. M., Hicklin, D. J., and Ferrone, S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol., 74: 181-273, 2000.
22. Weller, M., and Fontana, A. The failure of current immunotherapy for malignant glioma Tumor-derived TGF-β, T-cell apoptosis and the immune privilege of the brain. Brain. Res. Rev., 21: 128-151, 1995.
23. Zou, J. P., Morford, L. A., Chougnet, C., Dix, A. R., Brooks, A. G., Torres, N., Shuman, J. D., Coligan, J. E., Brooks, W. H., Roszman, T. L., and Shearer, G. M. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. J. Immunol., 162: 4882-4892, 1999.
24. Saas, P., Walker, P. R., Hahne, M., Quiquerez, A. L., Schnuriger, V., Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J., and Dietrich, P. Y. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Investig., 99: 1173-1178, 1997.
25. Weller, M., Kleihues, P., Dichgans, J., and Ohgaki, H. CD95 ligand: lethal weapon against malignant glioma? Brain. Pathol., 8: 285-293, 1998.
26. Paul, D. B., and Kruse, C. A., Immunologic approaches to therapy for brain tumors. Curr. Neurol. Neurosci. Rep., 1: 238-244, 2001.
27. Eppihimer, M. J., Gunn, J., Freeman, G. J., Greenfield, E. A., Chernova, T., Erickson, J., and Leonard, J. P. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothetial cells. Microcirculation, 9: 133-145, 2002.
28. Mazanet, M. M., and Hughes, C. C. B7-h1 is expressed by human endothelial cells and suppresses T-cell cytokine synthesis. J. Immunol., 169: 3581-3588, 2002.
29. Petroff, M. G., Chen, L., Phillips, T. A., and Hunt, J. S. B7 family molecules: novel immunomodulators at the maternal-fetal interface. Placenta., 23 (Suppl A): S95-S101, 2002.
30. Wiendl, H., Mitsdoerffer, M., Schneider, D., Chen, L., Lochmuller, H., Melms, A., and Weller, M. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J. 2003 Aug 15 [Epub ahead of print]: 101096/fj03-0039fje Published online August 15, 2003.
31. Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., and Freeman, G. J. Blockade of programmed death-1 ligands on dendritic cells enhances T-cell activation and cytokine production. J. Immunol., 170: 1257-1266, 2003.
32. Tamura, H., Dong, H., Zhu, G., Sica, G. L., Flies, D. B., Tamada, K., and Chen, L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood. 97: 1809-1816, 2001.
33. Selenko-Gebauer, N., Majdic, O., Szekeres, A., Hofler, G., Guthann, E., Korthauer, U., Zlabinger, G., Steinberger, P., Pickl, W. F., Stockinger, H., Knapp, W., and Stockl, J. B7-h1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T-cell anergy. J. Immunol., 170: 3637-3644, 2003.
34. Wang, S., Bajorath, J., Flies, D. B., Dong, H., Honjo, T., and Chen, L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med., 197: 1083-1091, 2003.
35. Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., and Minato, N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA, 99: 12293-12297, 2002.
36. Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., David, O., Burow, M., Gordon, A., Dhurandhar, N., Myers, L., Berggren, R., Hemminki, A., Alvarez, R. D., Emilie, D., Curiel, D. T., Chen, L., and Zou, W. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med., 9: 562-567, 2003.